Drug-resistant tuberculosis in high-risk groups, Zimbabwe
- PMID: 24377879
- PMCID: PMC3884722
- DOI: 10.3201/eid2001.130732
Drug-resistant tuberculosis in high-risk groups, Zimbabwe
Abstract
To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.
Keywords: HIV/TB; MDR TB; Mycobacterium tuberculosis; Zimbabwe; antimicrobial resistance; bacteria; drug-resistant tuberculosis; mycobacteria; retreatment tuberculosis; tuberculosis.
References
-
- World Health Organization. Multidrug and extensively drug-resistant tuberculosis: 2010 global report on surveillance and response. Geneva: The Organization; 2010. [cited 2013 Aug 22]. http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf
-
- World Health Organization. Global tuberculosis report 2012. [cited 2013 Jul 28]. http://www.who.int/tb/publications/global_report/en
-
- Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet. 2010;376:1244–53. 10.1016/S0140-6736(10)61425-0 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
